Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for

Ingredion (INGR) is set to report Q2 2025 earnings on August 1, with analysts forecasting a 3.1% year-over-year EPS decline to $2.78 per share on 1.3% higher revenues of $1.9 billion. Despite a 2.05% upward revision in consensus EPS estimates over the past 30 days and a history of beating estimates in the last four quarters, the company's 0% Zacks Earnings ESP, coupled with a Zacks Rank #2, indicates a lack of clear signal for an earnings beat, suggesting investors should evaluate broader business conditions beyond just the surprise potential.

Analysis

Ingredion (INGR) is approaching its Q2 2025 earnings report on August 1 with a mixed set of signals. The consensus forecast points to a potential margin contraction, with revenues expected to increase 1.3% year-over-year to $1.9 billion while earnings per share (EPS) are projected to decline by 3.1% to $2.78. Despite this anticipated YoY earnings decline, analyst sentiment has trended positively, reflected by a 2.05% upward revision in the consensus EPS estimate over the past 30 days. This is complemented by the company's strong execution history, having surpassed consensus EPS estimates in each of the last four quarters, including a significant 21.72% beat in the prior quarter. However, a key forward-looking indicator, the Zacks Earnings ESP, is currently 0%, suggesting no recent, divergent analyst revisions that would signal a likely earnings surprise. While the stock holds a favorable Zacks Rank of #2 (Buy), the neutral ESP makes it difficult to conclusively predict a beat, creating a divergence between the stock's positive historical performance and the model's neutral short-term outlook.

Key Decisions for Investors

• Given the conflicting signals of a strong earnings beat history versus a neutral 0% Earnings ESP, investors should treat the upcoming report with caution, as a beat is not strongly indicated by the predictive model.
• Focus primarily on management's commentary regarding the drivers behind the expected margin compression, as the reasons for a 3.1% earnings decline on 1.3% revenue growth will be more critical for the stock's trajectory than the headline numbers.
• While the Zacks Rank #2 is a positive factor, it may be prudent to await the actual results and forward guidance before initiating or adding to positions, as the lack of a positive ESP reduces the probability of a pre-earnings catalyst.